|
Name |
Isochromophilone X
|
Molecular Formula | C27H32ClNO7 | |
IUPAC Name* |
(E)-5-[(7S)-5-chloro-3-[(3E)-3,5-dimethylhepta-1,3-dienyl]-2-(2-hydroxyethyl)-7-methyl-6,8-dioxoisoquinolin-7-yl]oxy-3-methyl-5-oxopent-3-enoic acid
|
|
SMILES |
CCC(C)/C=C(\C)/C=CC1=CC2=C(C(=O)[C@@](C(=O)C2=CN1CCO)(C)OC(=O)/C=C(\C)/CC(=O)O)Cl
|
|
InChI |
InChI=1S/C27H32ClNO7/c1-6-16(2)11-17(3)7-8-19-14-20-21(15-29(19)9-10-30)25(34)27(5,26(35)24(20)28)36-23(33)13-18(4)12-22(31)32/h7-8,11,13-16,30H,6,9-10,12H2,1-5H3,(H,31,32)/b8-7?,17-11+,18-13+/t16?,27-/m0/s1
|
|
InChIKey |
ZRVRVSKUBHAMCG-KZIBRQSFSA-N
|
|
Synonyms |
Isochromophilone X
|
|
CAS | NA | |
PubChem CID | 139583930 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 518.0 | ALogp: | 4.8 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 121.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 36 | QED Weighted: | 0.186 |
Caco-2 Permeability: | -5.311 | MDCK Permeability: | 0.00003200 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.011 | 20% Bioavailability (F20%): | 0.141 |
30% Bioavailability (F30%): | 0.132 |
Blood-Brain-Barrier Penetration (BBB): | 0.566 | Plasma Protein Binding (PPB): | 88.45% |
Volume Distribution (VD): | 0.718 | Fu: | 13.84% |
CYP1A2-inhibitor: | 0.072 | CYP1A2-substrate: | 0.173 |
CYP2C19-inhibitor: | 0.253 | CYP2C19-substrate: | 0.863 |
CYP2C9-inhibitor: | 0.862 | CYP2C9-substrate: | 0.375 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.058 |
CYP3A4-inhibitor: | 0.801 | CYP3A4-substrate: | 0.504 |
Clearance (CL): | 0.994 | Half-life (T1/2): | 0.939 |
hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.85 |
Drug-inuced Liver Injury (DILI): | 0.953 | AMES Toxicity: | 0.356 |
Rat Oral Acute Toxicity: | 0.856 | Maximum Recommended Daily Dose: | 0.925 |
Skin Sensitization: | 0.919 | Carcinogencity: | 0.402 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
Respiratory Toxicity: | 0.919 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001870 | 0.778 | D05QDC | 0.231 | ||||
ENC002463 | 0.752 | D0B1IP | 0.230 | ||||
ENC006052 | 0.728 | D06BLQ | 0.221 | ||||
ENC003676 | 0.710 | D0WY9N | 0.219 | ||||
ENC006054 | 0.663 | D02DGU | 0.211 | ||||
ENC006053 | 0.645 | D0G3PI | 0.211 | ||||
ENC001841 | 0.541 | D00DKK | 0.211 | ||||
ENC004761 | 0.492 | D06FVX | 0.199 | ||||
ENC003626 | 0.484 | D0R3FP | 0.191 | ||||
ENC005593 | 0.473 | D06TNL | 0.187 |